AptarGroup, Inc. completed the acquisition of 49% stake in Suzhou Hsing Kwang, Suqian Hsing Kwang and Suzhou BTY for $32 million.
January 31, 2019
Share
AptarGroup, Inc. (NYSE:ATR) signed an agreement to acquire 49% stake in Suzhou Hsing Kwang, Suqian Hsing Kwang and Suzhou BTY on October 7, 2019. Pursuant to the terms of the acquisition, AptarGroup, Inc., will have the option to raise the stake in Suzhou Hsing Kwang, Suqian Hsing Kwang and Suzhou BTY in future years. The acquisition will be funded with available cash on hand. The transaction is subject to customary regulatory approvals and is expected to close by the end of 2019.
AptarGroup, Inc. (NYSE:ATR) completed the acquisition of 49% stake in Suzhou Hsing Kwang, Suqian Hsing Kwang and Suzhou BTY for $32 million on January 1, 2020.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
